(Q35934078)

11 August 2017

1 reference

title

Biologic rationale for the use of beta-blockers in the treatment of heart failure (English)

1 reference

11 August 2017

0 references

Hani N Sabbah

1

1 reference

11 August 2017

1 April 2004

1 reference

11 August 2017

Heart Failure Reviews

1 reference

11 August 2017

9

1 reference

11 August 2017

2

1 reference

11 August 2017

91-97

1 reference

https://scigraph.springernature.com/pub.10.1023/b:hrev.0000046363.59374.23

11 August 2017

0 references

cites work

Long-term beta-blockade in dilated cardiomyopathy. Effects of short- and long-term metoprolol treatment followed by withdrawal and readministration of metoprolol

1 reference

12 December 2020

Cardiac adrenergic receptor effects of carvedilol

1 reference

12 December 2020

Role of Ca2+ in toxic cell killing

1 reference

12 December 2020

Changes in myocardial and vascular receptors in heart failure

1 reference

12 December 2020

Cardiovascular injury induced by sympathetic catecholamines

1 reference

12 December 2020

Role of beta-adrenergic receptor downregulation in the peak exercise response in patients with heart failure due to idiopathic dilated cardiomyopathy

1 reference

12 December 2020

Increased beta-receptor density and improved hemodynamic response to catecholamine stimulation during long-term metoprolol therapy in heart failure from dilated cardiomyopathy

1 reference

12 December 2020

Relationship between action potential, contraction-relaxation pattern, and intracellular Ca2+ transient in cardiomyocytes of dogs with chronic heart failure.

1 reference

12 December 2020

Evidence of cardiocyte apoptosis in myocardium of dogs with chronic heart failure.

1 reference

12 December 2020

Relation between myocardial function and expression of sarcoplasmic reticulum Ca(2+)-ATPase in failing and nonfailing human myocardium

1 reference

12 December 2020

Bcl-2 expression prevents activation of the ICE protease cascade

1 reference

12 December 2020

Improvement in symptoms and exercise tolerance by metoprolol in patients with dilated cardiomyopathy: a double-blind, randomized, placebo-controlled trial

1 reference

12 December 2020

Effects of long-term monotherapy with enalapril, metoprolol, and digoxin on the progression of left ventricular dysfunction and dilation in dogs with reduced ejection fraction

1 reference

12 December 2020

Adrenergic effects on the biology of the adult mammalian cardiocyte

1 reference

12 December 2020

31P magnetic resonance spectroscopy in dilated cardiomyopathy and coronary artery disease. Altered cardiac high-energy phosphate metabolism in heart failure

1 reference

12 December 2020

SR Ca(2+)-ATPase activity and expression in ventricular myocardium of dogs with heart failure

1 reference

12 December 2020

Changes in gene expression in the intact human heart. Downregulation of alpha-myosin heavy chain in hypertrophied, failing ventricular myocardium.

1 reference

12 December 2020

Hypoxia induces apoptosis with enhanced expression of Fas antigen messenger RNA in cultured neonatal rat cardiomyocytes

1 reference

12 December 2020

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

1 reference

12 December 2020

Apoptosis in heart failure

1 reference

12 December 2020

Controlling cell death

1 reference

12 December 2020

Mechanism of action of beta-blocking agents in heart failure

1 reference

12 December 2020

Cellular mechanisms in congestive heart failure

1 reference

12 December 2020

Reduced Contraction and Altered Frequency Response of Isolated Ventricular Myocytes From Patients With Heart Failure

1 reference

12 December 2020

Effects of metoprolol on rest and exercise cardiac function and plasma catecholamines in chronic congestive heart failure secondary to ischemic or idiopathic cardiomyopathy

1 reference

12 December 2020

beta Adrenergic receptor desensitisation may serve a cardioprotective role

1 reference

12 December 2020

Apoptosis of cardiac myocytes in Gsalpha transgenic mice

1 reference

12 December 2020

Intracoronary infusion of dobutamine to patients with and without severe congestive heart failure. Dose-response relationships, correlation with circulating catecholamines, and effect of phosphodiesterase inhibition

1 reference

12 December 2020

Beta-receptor blockade decreases carnitine palmitoyl transferase I activity in dogs with heart failure

1 reference

12 December 2020

Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure. US Carvedilol Heart Failure Study Group

1 reference

12 December 2020

Myosin heavy chain isoform expression in the failing and nonfailing human heart

1 reference

12 December 2020

Programmed myocyte cell death affects the viable myocardium after infarction in rats

1 reference

12 December 2020

Comparative hemodynamic, left ventricular functional, and antiadrenergic effects of chronic treatment with metoprolol versus carvedilol in the failing heart

1 reference

12 December 2020

Chronic therapy with metoprolol attenuates cardiomyocyte apoptosis in dogs with heart failure

1 reference

12 December 2020

Beneficial effects of metoprolol in heart failure associated with coronary artery disease: a randomized trial

1 reference

12 December 2020

Sarcoplasmic reticulum gene expression in cardiac hypertrophy and heart failure.

1 reference

12 December 2020

Effect of metoprolol on myocardial function and energetics in patients with nonischemic dilated cardiomyopathy: a randomized, double-blind, placebo-controlled study

1 reference

12 December 2020

Gene expression of the cardiac Na(+)-Ca2+ exchanger in end-stage human heart failure

1 reference

12 December 2020

Norepinephrine stimulates apoptosis in adult rat ventricular myocytes by activation of the beta-adrenergic pathway

1 reference

12 December 2020

Relation between ventricular and myocyte function with tachycardia-induced cardiomyopathy

1 reference

12 December 2020

Myosin heavy chain regulation and myocyte contractile depression after LV hypertrophy in aortic-banded mice

1 reference

12 December 2020

Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents

1 reference

12 December 2020

Assessment of the beta-adrenergic receptor pathway in the intact failing human heart: progressive receptor down-regulation and subsensitivity to agonist response

1 reference

12 December 2020

Altered expression of beta-adrenergic receptor kinase and beta 1-adrenergic receptors in the failing human heart.

1 reference

12 December 2020

Free fatty acid kinetics and oxidation in congestive heart failure.

1 reference

12 December 2020

Pathophysiological targets for beta-blocker therapy in congestive heart failure

1 reference

12 December 2020

Increase of the 40,000-mol wt pertussis toxin substrate (G protein) in the failing human heart

1 reference

12 December 2020

Isoproterenol-induced myocardial fibrosis in relation to myocyte necrosis

1 reference

12 December 2020

Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators.

1 reference

12 December 2020

Dose-response of chronic beta-blocker treatment in heart failure from either idiopathic dilated or ischemic cardiomyopathy. Bucindolol Investigators

1 reference

12 December 2020

Decreased Gs alpha mRNA levels accompany the fall in Gs and adenylyl cyclase activities in compensated left ventricular hypertrophy. In heart failure, only the impairment in adenylyl cyclase activation progresses

1 reference

12 December 2020

Selective beta 1-adrenoceptor blockade enhances positive inotropic responses to endogenous catecholamines mediated through beta 2-adrenoceptors in human atrial myocardium

1 reference

12 December 2020

Progression of heart failure: a role for interstitial fibrosis

1 reference

12 December 2020

Should manipulation of myocardial substrate utilization patterns be a component of the congestive heart failure therapeutic paradigm?

1 reference

12 December 2020

Effects of long-term monotherapy with metoprolol CR/XL on the progression of left ventricular dysfunction and remodeling in dogs with chronic heart failure

1 reference

12 December 2020

Medical therapy can improve the biological properties of the chronically failing heart. A new era in the treatment of heart failure

1 reference

12 December 2020

Beta-adrenergic neuroeffector abnormalities in the failing human heart are produced by local rather than systemic mechanisms

1 reference

12 December 2020

Dietary medium-chain triglycerides can prevent changes in myosin and SR due to CPT-1 inhibition by etomoxir

1 reference

12 December 2020

10.1023/B:HREV.0000046363.59374.23

Identifiers

DOI

1 reference

PubMed ID

15516856

Dimensions Publication ID

11 August 2017

0 references

1 reference

PubMed ID

15516856